Neurogene Inc. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/16ac0e33-d993-4de9-aa71-f7307453ea2c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001404644-26-000019 |
| FY 2024 | $925.0k | 2024-01-01 – 2024-12-31 | evidence 0001404644-25-000012 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001404644-25-000012 |
| FY 2018 | $25.0M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-066506 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).